Found: 16
Select item for more details and to access through your institution.
Development of a selective estrogen β‐receptor phytoestrogen formulation – PhytoSERM – for the reduction of Alzheimer's risk and relief of menopausal symptoms in women: a phase 2 randomized clinical trial framework.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.080295
- By:
- Publication type:
- Article
Sex‐ and APOE‐Specific Transcriptomic Signatures in Alzheimer's Disease: An AZ‐ADRC‐Research Education Scholars Team Science Project.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080270
- By:
- Publication type:
- Article
In‐season docosahexaenoic acid supplementation does not prevent white matter damage during a single American football season: Implications for neurodegeneration prevention.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 1, doi. 10.1002/alz.065751
- By:
- Publication type:
- Article
Allopregnanolone as a Regenerative Therapeutic for Alzheimer's Disease: Phase 2 proof‐of‐concept clinical trial using hippocampal volume as a surrogate endpoint.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.068251
- By:
- Publication type:
- Article
Precision Functional Assessment for Alzheimer's disease (PFA‐AD): A pilot study framework.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046289
- By:
- Publication type:
- Article
Pharmacokinetics and safety profile of intramuscular administration of allopregnanolone in patients with Alzheimer's disease: Human/Human trials: Other.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046223
- By:
- Publication type:
- Article
P3‐032: COMBINING SEX, APOE GENOTYPE, AND MITOCHONDRIAL GENETIC VARIANCE AS PREDICTIVE RESPONDER IDENTIFIER TO REGENERATIVE THERAPEUTIC ALLOPREGNANOLONE FOR ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P938, doi. 10.1016/j.jalz.2019.06.3058
- By:
- Publication type:
- Article
P3‐015: ALLOPREGNANOLONE SHOWS SIGNIFICANT EFFECT ON THE LIPID PATHWAYS FROM PLASMA METABOLOMIC ANALYSIS OF ALZHEIMER'S CLINICAL TRIAL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P930, doi. 10.1016/j.jalz.2019.06.3041
- By:
- Publication type:
- Article
P2‐027: PHARMACOKINETICS AND SAFETY PROFILE OF SINGLE‐DOSE ADMINISTRATION OF AN ESTROGEN RECEPTOR β‐SELECTIVE PHYTOESTROGENIC (PHYTOSERM) FORMULATION IN WOMEN WITH COGNITIVE DEFICITS AND MENOPAUSAL SYMPTOMS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P581, doi. 10.1016/j.jalz.2019.06.1249
- By:
- Publication type:
- Article
P1‐015: BLOOD‐BASED INFLAMMATORY BIOMARKERS FOR PREDICTING THERAPEUTIC RESPONSE IN REGIONAL BRAIN VOLUME CHANGES IN PATIENTS WITH ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P236, doi. 10.1016/j.jalz.2019.06.040
- By:
- Publication type:
- Article
P1‐053: PHARMACOKINETICS AND SAFETY PROFILE OF INTRAVENOUS ADMINISTRATION OF ALLOPREGNANOLONE IN PATIENTS WITH EARLY ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P288, doi. 10.1016/j.jalz.2018.06.055
- By:
- Publication type:
- Article
P1‐018: MITOCHONDRIAL HAPLOGROUP IN COMBINATION WITH APOE GENOTYPE AS POTENTIAL PREDICTIVE BIOMARKER TO IDENTIFY RESPONDERS TO REGENERATIVE THERAPEUTIC ALLOPREGNANOLONE FOR ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P271, doi. 10.1016/j.jalz.2018.06.019
- By:
- Publication type:
- Article
Effects of docosahexaenoic acid and eicosapentaoic acid supplementation on white matter integrity after repetitive sub-concussive head impacts during American football: Exploratory neuroimaging findings from a pilot RCT.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.891531
- By:
- Publication type:
- Article
Exploratory imaging outcomes of a phase 1b/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: Structural effects and functional connectivity outcomes.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2022, v. 8, n. 1, p. 1, doi. 10.1002/trc2.12258
- By:
- Publication type:
- Article
Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2020, v. 6, n. 1, p. 1, doi. 10.1002/trc2.12107
- By:
- Publication type:
- Article
Effects of Fish Oil on Biomarkers of Axonal Injury and Inflammation in American Football Players: A Placebo-Controlled Randomized Controlled Trial.
- Published in:
- Nutrients, 2022, v. 14, n. 10, p. 2139, doi. 10.3390/nu14102139
- By:
- Publication type:
- Article